DHR Jan 2024 250.000 call
| Previous close | 0.6000 |
| Open | 0.5000 |
| Bid | 0.3000 |
| Ask | 0.4500 |
| Strike | 250.00 |
| Expiry date | 2024-01-19 |
| Day's range | 0.5000 - 0.6000 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.07k |
Insider Monkey$5 Billion Hedge Fund Skye Global’s Top 15 Stock Picks
In this article, we will be taking a look at the $5 billion hedge fund Skye Global’s top 15 stock picks. To skip our detailed analysis of the hedge fund Skye Global, you can go directly to see the $5 Billion Hedge Fund Skye Global’s Top 5 Stock Picks. Rarely does a 28-year-old succeed in raising $75 […]
ZacksDanaher (DHR) Acquires Abcam to Boost Life Sciences Segment
Danaher (DHR) acquires Abcam for $5.7 billion, thus adding to its Life Sciences portfolio. This move will facilitate the mapping of complex diseases and expedite the drug discovery process.
- Reuters
UPDATE 1-Danaher completes $5.7 billion acquisition of Abcam
Medical tools supplier Danaher said on Wednesday it has completed the $5.7 billion acquisition of Abcam, overcoming the initial opposition from the founder of the protein consumables maker. Danaher agreed to buy Abcam in September for $24 per share to expand its portfolio of products and services, but founder Jonathan Milner opposed it saying the offer undervalued the company. Milner, who owns a 6.14% stake, had said he would vote against the acquisition.
